½ÃÀ庸°í¼­
»óǰÄÚµå
1453888

ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çüº°, À¯·¡º°, Á¦Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

Protease Enzyme Market Forecasts to 2030 - Global Analysis By Type (Aspartic Proteases, Cysteine Proteases & Other Types), Source (From Plants, From Animals & Genetically Modified Organisms (GMOs)), Formulation, Application, End User & By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 6.7%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â ´Ü¹éÁú ºÐÇØ È¿¼Ò ¶Ç´Â ÆéƼ´ÙÁ¦¶ó°íµµ Çϸç, ´Ü¹éÁúÀ» ´õ ÀÛÀº ÆéŸÀ̵å¿Í ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØÇÏ´Â È¿¼ÒÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. ¼ÒÈ­, ¼¼Æ÷ Á¶Àý, ´Ü¹éÁú ´ë»ç µî ´Ù¾çÇÑ »ý¹°ÇÐÀû °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦´Â ´Ù¾çÇÑ È¿¼Ò Ȱ¼ºÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦´Â ´Ü¹éÁú ±â¹Ý ¿À¿°¹°ÁúÀ» ºÐÇØÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¼¼Á¦¿¡µµ »ç¿ëµÇ¸ç, ´Ü¹éÁú °øÇÐ ¹× ¿¬±¸ ¸ñÀûÀÇ »ý¸í°øÇп¡¼­ ÇÁ·ÎÅ×¾ÆÁ¦´Â ¸é¿ª ¹ÝÀÀ¿¡ °ü¿©ÇÏ¿© ¿Ü·¡ ´Ü¹éÁú°ú º´¿ø±ÕÀ» ÆÄ±«ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

DSM Nutritional Products AG°¡ ½Ç½ÃÇÑ Á¶»ç¿¡ µû¸£¸é ¹Ì±¹ ¹Ð·¹´Ï¾ó ¼¼´ë´Â Æò»ý µ¿¾È ¸Å´Þ 155´Þ·¯¸¦ °Ç°­¿¡ ÁöÃâÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

ÀǾàǰ¿¡ ´ëÇÑ Àû¿ë È®´ë

ÀǾàǰ¿¡¼­ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼ÒÀÇ »ç¿ë È®´ë´Â ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁøÁ¦ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¿¼Ò´Â ÀǾàǰ °³¹ß ¹× Á¦Á¶ °øÁ¤, ƯÈ÷ Àν¶¸° ¹× Ç×ü¿Í °°Àº ¹ÙÀÌ¿ÀÀǾàǰÀÇ Á¦Á¶¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â ´Ù¾çÇÑ Ä¡·áÁ¦ÀÇ Á¦Çü¿¡ äÅõǾî È¿´É°ú »ýü ÀÌ¿ë·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ±â¼úÀÇ ¹ßÀüÀ¸·Î Ç¥Àû ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡µµ Ȱ¿ëµÇ¾î º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ Ä¡·á ¹æ¹ýÀÌ °¡´ÉÇØÁ³½À´Ï´Ù.

°í±Þ ¿¬±¸ °³¹ß

½Å±Ô ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò °³¹ßÀº ÀûÀýÇÑ ±ÕÁÖ¸¦ ã¾Æ³»°í, »ý»ê °øÁ¤À» ÃÖÀûÈ­Çϰí, È¿´É°ú ¾ÈÀü¼ºÀ» º¸ÀåÇϱâ À§ÇÑ ±¤¹üÀ§ÇÑ ¿¬±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ³ë·Â¿¡´Â ½ÇÇè½Ç, Àåºñ, ¼÷·ÃµÈ Àη¿¡ ´ëÇÑ ¸·´ëÇÑ ÀÚ±Ý ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ¹ý±Ô¸¦ ÁؼöÇÏ´Â °Íµµ ºñ¿ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÕ´Ï´Ù. ±× °á°ú, ½Å±Ô ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò °³¹ß ºñ¿ëÀÌ ¾öû³ª°Ô ³ô¾ÆÁ® ½ÃÀå °³Ã´¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮Àº ½Å±Ô ÁøÀÔ ±â¾÷ÀÇ ÁøÀÔÀ» Á¦ÇÑÇϰí Á¦Ç° °¡°Ý »ó½ÂÀ¸·Î À̾îÁú ¼ö Àֱ⠶§¹®¿¡ ½ÃÀå È®´ë¿Í Á¢±Ù¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½Äǰ »ê¾÷

½Äǰ »ê¾÷Àº ´Ù¾çÇÑ ¿ëµµ·Î ÀÎÇØ Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â ½Äǰ °¡°ø¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¸ç ´Ü¹éÁú ºÐÇØ¿¡ µµ¿òÀ» ÁÖ¾î dz¹Ì, Áú°¨, ¿µ¾ç°¡¸¦ Çâ»ó½Ãŵ´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â À¯Á¦Ç°, º£ÀÌÄ¿¸®, À°·ù °¡°ø, À½·á Á¦Á¶ µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ »ç¿ëµÇ¾î Á¦Ç°ÀÇ Ç°Áú°ú º¸Á¸¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÚ¿¬½º·´°í ±ú²ýÇÑ ¶óº§ÀÌ ºÙÀº Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â ½Äǰ Á¦Á¶¾÷ü°¡ Á¦Ç°ÀÇ Àϰü¼º°ú ǰÁúÀ» À¯ÁöÇϸ鼭 ÀÌ·¯ÇÑ ¼±È£µµ¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â Áö¼Ó°¡´ÉÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ´Ü¹éÁúÀÇ ¼ÒÈ­ ¹× Èí¼ö¿Í °ü·ÃµÈ °Ç°­ È¿°ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ±â´É¼º ½Äǰ ¹× °Ç°­ º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼ÒÀÇ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿øÀç·áÀÇ °¡¿ë¼º

¿ø·á °¡¿ë¼º À§ÇùÀº È¿¼Ò »ý»ê¿¡ ÇÊ¿äÇÑ ÁÖ¿ä ¿ø·á °ø±ÞÀÇ º¯µ¿°ú Á¦¾àÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â À§ÇèÀÔ´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â ÀϹÝÀûÀ¸·Î ½Ä¹°, µ¿¹°, ¹Ì»ý¹°°ú °°Àº »ý¹°ÇÐÀû °ø±Þ¿ø¿¡¼­ À¯·¡Çϱ⠶§¹®¿¡ »ý»êÀº ³óÀÛ¹°À̳ª ¹ßÈ¿ ±âÁú°ú °°Àº ƯÁ¤ ¿ø·á¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. ȯ°æÀû ¿äÀÎ, ÁöÁ¤ÇÐÀû ¹®Á¦ ¶Ç´Â ½ÃÀå ¿ªÇÐÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ ¿øÀÚÀç °ø±Þ¸Á¿¡ È¥¶õÀÌ ¹ß»ýÇϸé ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼ÒÀÇ °¡¿ë¼º°ú ºñ¿ë¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯µ¿Àº »ý»ê ºñ¿ë »ó½Â, ¼öÀͼº °¨¼Ò ¶Ç´Â ½ÃÀå¿¡¼­ÀÇ Á¦Ç° ºÎÁ·À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

COVID-19´Â ¸î °¡Áö Ãø¸é¿¡¼­ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ù°, COVID-19 Áø´Ü °Ë»ç ¹× ¿¬±¸¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÃËÁøÇß½À´Ï´Ù. µÑ°, ¼¼°è °ø±Þ¸ÁÀÇ È¥¶õÀº ¿ø·á Á¶´Þ ¹× Á¦Á¶¿¡ ¾î·Á¿òÀ» ÃÊ·¡ÇÏ¿© ÀáÀçÀûÀÎ °ø±Þ ºÎÁ·°ú °¡°Ý º¯µ¿À» ÀÏÀ¸Ä×½À´Ï´Ù. ¼Â°, COVID-19 Ä¡·áÁ¦ ¹× ¹é½Å °³¹ß¿¡ ÁýÁßÇϸ鼭 ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ°¡ Áõ°¡ÇÏ¿© ½ÃÀåÀÌ È®´ëµÇ¾ú½À´Ï´Ù. ±×·¯³ª °æ±â ħü¿Í ¿¹»ê Á¦¾àÀº ½ÃÀå ¼ºÀåÀ» ¾î´À Á¤µµ ¾ïÁ¦Çß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦ ºÎ¹®ÀÌ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»ó

¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦´Â ¼ÒÈ­, Ç÷¾× ÀÀ°í, ¸é¿ª ¹ÝÀÀ Á¶Àý µî ´Ù¾çÇÑ »ý¹°ÇÐÀû °úÁ¤¿¡¼­ÀÇ Áß¿äÇÑ ¿ªÇÒ·Î ÀÎÇØ Á¦¾à, ½Äǰ, ¿¬±¸ ºÐ¾ß Àü¹Ý¿¡¼­ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾Ï ¹× ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ±¤¹üÀ§ÇÑ ¿¬±¸ °³¹ßÀ» ÇÊ¿ä·Î Çϸç, ½Å¾à °³¹ß ¹× Ä¡·á¿ë ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ »ê¾÷, ƯÈ÷ ±â´É¼º ½Äǰ ¹× °Ç°­ º¸Á¶ ½ÄǰÀÇ È®´ë´Â ½Äǰ °¡°øÀ» µ½°í ¿µ¾ç ǰÁúÀ» Çâ»ó½ÃŰ´Â ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ã۰í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â µ¿¹° »ç·á ºÐ¾ßÀÔ´Ï´Ù.

µ¿¹° »ç·á ºÐ¾ß´Â °¡Ãà »ý»êÀÚµé »çÀÌ¿¡¼­ °¡ÃàÀÇ ¼ºÀå°ú ¼º´ÉÀ» Çâ»ó½Ã۱â À§ÇØ °¡ÃàÀÇ ¿µ¾çÀ» ÃÖÀûÈ­ÇÏ´Â °ÍÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò´Â »ç·á ³» ´Ü¹éÁúÀ» ºÐÇØÇÏ¿© µ¿¹°ÀÇ ¼ÒÈ­À²°ú ¿µ¾ç Èí¼öÀ²À» Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °íǰÁú µ¿¹°¼º ´Ü¹éÁú Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ý»ê È¿À²À» ±Ø´ëÈ­Çϱâ À§ÇØ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò¿Í °°Àº º¸´Ù È¿À²ÀûÀÎ »ç·á ÷°¡Á¦°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãà»ê¾÷°ú °ü·ÃµÈ ȯ°æ ¿µÇâÀ» ÁÙ¿©¾ß ÇÑ´Ù´Â ±ÔÁ¦Àû ¾Ð·Âµµ »ç·á ÀüȯÀ²À» °³¼±ÇÏ°í Æó±â¹°À» ÃÖ¼ÒÈ­Çϱâ À§ÇØ È¿¼Ò¸¦ »ç¿ëÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë ½ÃÀå Á¡À¯À²À» °¡Áø Áö¿ª

ºÏ¹Ì Áö¿ªÀº ½ÄÀ½·á, Á¦¾à, ¼¼Á¦ µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ÅºÅºÇÑ R&D ÀÎÇÁ¶ó¿Í »ý¸í°øÇÐ ¿¬±¸¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ´Â ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼ÒÀÇ »ý»ê ¹× ÀÀ¿ë ºÐ¾ß¿¡¼­ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò »ç¿ë¿¡ ´ëÇÑ ±ÔÁ¦Àû Áö¿øµµ ºÏ¹Ì ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò°¡ »ê¾÷ °øÁ¤ ¹× Á¦Ç° ǰÁú Çâ»ó¿¡ ¹ÌÄ¡´Â ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå È®´ë°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÄÀ½·á °¡°ø, »ç·á, ÀǾàǰ µî ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ °¡°ø½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ±â¾÷µéÀÌ Áö¿ª ÃëÇâ¿¡ ¸Â´Â »õ·Î¿î È¿¼Ò Á¦Ç°À» Çõ½ÅÇϱâ À§ÇØ R&D Ȱµ¿¿¡ ÅõÀÚÇÏ´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒÈ­¸¦ °³¼±ÇÏ°í ¿µ¾ç°¡¸¦ ³ôÀÌ´Â ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼ÒÀÇ ´Ù¸¥ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °Ç°­ º¸Á¶ ½Äǰ ¹× ÀǾàǰÀÇ ¼Òºñ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ Á¦°ø:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : À¯Çüº°

  • ¾Æ½ºÆÄ¶ó±ä»ê ÇÁ·ÎÅ×¾ÆÁ¦
  • ½Ã½ºÅ×ÀÎ ÇÁ·ÎÅ×¾ÆÁ¦
  • ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦
  • ¸ÞÅ»·ÎÇÁ·ÎÅ×¾ÆÁ¦
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : À¯·¡º°

  • ½Ä¹°
  • µ¿¹°
  • ¹Ì»ý¹°
  • À¯ÀüÀÚ ÀçÁ¶ÇÕ »ý¹°(GMO)

Á¦7Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : Á¦Á¦º°

  • ¾×ü
  • °ú¸³
  • ºÐ¸»

Á¦8Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : ¿ëµµº°

  • ÇÇÇõ °¡°ø
  • ¼¼Á¦
  • ÅØ½ºÅ¸ÀÏ
  • µ¿¹° »ç·á
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½Äǰ¡¤À½·á
  • ÀǾàǰ
  • Æó±â¹° °ü¸®
  • ¹ÙÀÌ¿À¿¬·á »ý»ê
  • °¡Á¤
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ÇÁ·ÎÅ×¾ÆÁ¦ È¿¼Ò ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Ab Enzymes
  • Advanced Enzymes
  • Amano Enzymes
  • Dyadic International
  • E.I. Dupont De Nemours & Company
  • Jiangsu Boli Bioproducts
  • Novozymes
  • Royal Dsm
  • Solvay Enzymes
  • Specialty Enzymes & Probiotics
ksm 24.04.29

According to Stratistics MRC, the Global Protease Enzyme Market is growing at a CAGR of 6.7% during the forecast period. Protease enzymes, also known as proteolytic enzymes or peptidases, are a class of enzymes responsible for breaking down proteins into smaller peptides or amino acids. They play crucial roles in various biological processes, including digestion, cellular regulation, and protein turnover. They are widely used across various sectors due to their versatile enzymatic activity. Proteases are also employed in detergents for their ability to break down protein-based stains and in biotechnology for protein engineering and research purposes, proteases are involved in the immune response, where they help in the destruction of foreign proteins and pathogens.

According to a survey conducted by DSM Nutritional Products AG, over the course of their lives, an American millennial spends US$155 per month on health.

Market Dynamics:

Driver:

Expanding applications in pharmaceuticals

The expanding applications of protease enzymes in pharmaceuticals serve as a significant driver for the protease enzyme market. These enzymes play a crucial role in drug development and manufacturing processes, particularly in the production of biopharmaceuticals such as insulin and antibodies. Moreover, protease enzymes are employed in the formulation of various therapeutic drugs to enhance their efficacy and bioavailability. Additionally, advancements in protease enzyme technology have led to their utilization in targeted drug delivery systems, enabling more precise and efficient treatment modalities.

Restraint:

High research and development

Developing novel protease enzymes involves extensive research to identify suitable strains, optimize production processes, and ensure efficacy and safety. These endeavors demand substantial financial investment in laboratories, equipment, and skilled personnel. Additionally, regulatory compliance adds to the expenses. As a result, the cost of developing new protease enzymes can be prohibitive, hindering market growth. This barrier limits the entry of new players and may lead to higher product prices, thereby impacting market expansion and accessibility.

Opportunity:

Food industry

The food industry presents a significant opportunity due to their diverse applications. Protease enzymes play a crucial role in food processing, aiding in the breakdown of proteins to improve flavor, texture, and nutritional value. They are used in various segments, such as dairy, bakery, meat processing, and beverage production, to enhance product quality and shelf life. With increasing consumer demand for natural and clean-label products, protease enzymes offer a sustainable solution for food manufacturers to meet these preferences while maintaining product consistency and quality. Furthermore, the growing awareness of the health benefits associated with protein digestion and absorption further drives the demand for protease enzymes in functional foods and dietary supplements.

Threat:

Raw material availability

The raw material availability threats are the risks posed by fluctuations or constraints in the supply of key ingredients needed for enzyme production. Protease enzymes are typically derived from biological sources like plants, animals, or microorganisms, making their production reliant on specific raw materials such as agricultural crops or fermentation substrates. Any disruption in the supply chain of these raw materials, whether due to environmental factors, geopolitical issues, or market dynamics, can directly impact the availability and cost of protease enzymes. Such fluctuations may lead to increased production costs, reduced profitability, or even shortages in the market.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the protease enzyme market in several ways. Firstly, there was a surge in demand for protease enzymes due to their vital role in COVID-19 diagnostic tests and research, driving market growth. Secondly, disruptions in the global supply chain led to challenges in raw material sourcing and manufacturing, causing potential shortages and price fluctuations. Thirdly, the focus on developing therapeutics and vaccines for COVID-19 increased R&D investments in protease enzyme-based treatments, expanding the market. However, economic downturns and budget constraints had tempered market growth to some extent.

The serine proteases segment is expected to be the largest during the forecast period

Serine proteases represent a significant segment within the protease enzyme market, experiencing notable growth due to their crucial roles in various biological processes, including digestion, blood clotting, and immune response regulation, driving demand across the pharmaceutical, food, and research sectors. The increasing prevalence of chronic diseases such as cancer and cardiovascular disorders necessitates extensive research and development, spurring demand for serine proteases in drug discovery and therapeutic applications. Additionally, the expanding food industry, particularly functional foods and dietary supplements, amplifies the demand for serine proteases as they aid in food processing and improve nutritional quality.

The animal feed segment is expected to have the highest CAGR during the forecast period

The animal feed segment has experienced significant growth due to growing awareness among livestock producers regarding the importance of optimizing animal nutrition for enhanced growth and performance. Protease enzymes play a crucial role in breaking down proteins in feed, improving their digestibility and nutrient absorption for animals. As the demand for high-quality animal protein products rises globally, there's a corresponding need for more efficient feed additives like protease enzymes to maximize production efficiency. Additionally, regulatory pressures to reduce environmental impacts associated with animal agriculture have also incentivized the use of enzymes to improve feed conversion ratios and minimize waste.

Region with largest share:

North American region has witnessed significant growth in the protease enzyme market, driven by increasing demand for protease enzymes across various industries, including food and beverage, pharmaceuticals, and detergents. Moreover, the region's robust research and development infrastructure, coupled with substantial investments in biotechnology research, have propelled innovation in protease enzyme production and application. Regulatory support for the use of protease enzymes in various applications has also contributed to market growth in North America. Furthermore, heightened awareness regarding the benefits of protease enzymes in improving industrial processes and product quality has stimulated market expansion.

Region with highest CAGR:

The Asia-Pacific region has experienced substantial growth in the protease enzyme market due to increasing demand for processed food in various applications such as food and beverage processing, animal feed, and pharmaceuticals. Moreover, the presence of key market players investing in research and development activities to innovate new enzyme products tailored to regional preferences has further stimulated market growth. Additionally, rising awareness about the benefits of protease enzymes in improving digestion and enhancing nutritional value has boosted their consumption in dietary supplements and pharmaceutical products.

Key players in the market

Some of the key players in Protease Enzyme market include Ab Enzymes , Advanced Enzymes, Amano Enzymes, Dyadic International, E.I. Dupont De Nemours & Company, Jiangsu Boli Bioproducts, Novozymes, Royal Dsm, Solvay Enzymes and Specialty Enzymes & Probiotics.

Key Developments:

In February 2024, Dyadic International, Inc and Israel Institute for Biological Research (IIBR) announced it has advanced its collaboration with the Israel Institute for Biological Research (IIBR) and its commercial arm Life Science Research Israel (LSRI), to target emerging disease solutions. This partnership aims to leverage Dyadic's expertise in microbial platforms for flexible scale protein bioproduction and the IIBR's antibodies and antigens discovery capabilities to develop and manufacture innovative solutions for addressing emerging diseases and potential bio-threats.

In February 2024, Novozymes and Chr. Hansen have completed their merger, creating a company called Novonesis that has 10,000 employees, a global network of research and development and application centers and activity in 30 industries. Annual revenue will be about €3.7 billion ($4 billion).

Types Covered:

  • Aspartic Proteases
  • Cysteine Proteases
  • Serine Proteases
  • Metalloproteases
  • Other Types

Sources Covered:

  • Plants
  • Animals
  • Microorganisms
  • Genetically Modified Organisms (GMOs)

Formulations Covered:

  • Liquid
  • Granules
  • Powder

Applications Covered:

  • Leather Processing
  • Detergents
  • Textiles
  • Animal Feed
  • Other Applications

End Users Covered:

  • Food & Beverages
  • Pharmaceuticals
  • Waste Management
  • Biofuel Production
  • Household
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Protease Enzyme Market, By Type

  • 5.1 Introduction
  • 5.2 Aspartic Proteases
  • 5.3 Cysteine Proteases
  • 5.4 Serine Proteases
  • 5.5 Metalloproteases
  • 5.6 Other Types

6 Global Protease Enzyme Market, By Source

  • 6.1 Introduction
  • 6.2 Plants
  • 6.3 Animals
  • 6.4 Microorganisms
  • 6.5 Genetically Modified Organisms (GMOs)

7 Global Protease Enzyme Market, By Formulation

  • 7.1 Introduction
  • 7.2 Liquid
  • 7.3 Granules
  • 7.4 Powder

8 Global Protease Enzyme Market, By Application

  • 8.1 Introduction
  • 8.2 Leather Processing
  • 8.3 Detergents
  • 8.4 Textiles
  • 8.5 Animal Feed
  • 8.6 Other Applications

9 Global Protease Enzyme Market, By End User

  • 9.1 Introduction
  • 9.2 Food & Beverages
  • 9.3 Pharmaceuticals
  • 9.4 Waste Management
  • 9.5 Biofuel Production
  • 9.6 Household
  • 9.7 Other End Users

10 Global Protease Enzyme Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Ab Enzymes
  • 12.2 Advanced Enzymes
  • 12.3 Amano Enzymes
  • 12.4 Dyadic International
  • 12.5 E.I. Dupont De Nemours & Company
  • 12.6 Jiangsu Boli Bioproducts
  • 12.7 Novozymes
  • 12.8 Royal Dsm
  • 12.9 Solvay Enzymes
  • 12.10 Specialty Enzymes & Probiotics
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦